Cargando…

Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases

BACKGROUND & OBJECTIVE: Bacterial, contamination of blood components are a significant risk for transfusion reactions. Inherently, platelet concentrates (PCs) are vulnerable to bacterial contamination, due to the storage condition of processed PCs at room temperature, which provide very suitable...

Descripción completa

Detalles Bibliográficos
Autores principales: Razjou, Farhad, Dabir Moghaddam, Abolfazl, Karimi, Gharib, Zadsar, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831066/
https://www.ncbi.nlm.nih.gov/pubmed/29515632
_version_ 1783303119791194112
author Razjou, Farhad
Dabir Moghaddam, Abolfazl
Karimi, Gharib
Zadsar, Maryam
author_facet Razjou, Farhad
Dabir Moghaddam, Abolfazl
Karimi, Gharib
Zadsar, Maryam
author_sort Razjou, Farhad
collection PubMed
description BACKGROUND & OBJECTIVE: Bacterial, contamination of blood components are a significant risk for transfusion reactions. Inherently, platelet concentrates (PCs) are vulnerable to bacterial contamination, due to the storage condition of processed PCs at room temperature, which provide very suitable conditions for the proliferation of microorganisms. The current study aimed at investigating the transfusion associated septic reaction rate in patients with hemato-oncological diseases in Imam Khomeini Hospital, Tehran, Iran, and identifying the contaminating bacteria. METHODS: A total of 3056 adult patients of the Cancer Center of Imam Khomeini Hospital in Tehran transfused with PCs were studied based on the clinical symptoms of septic transfusion reaction from June 1, 2010 to May 31, 2011. Patient presented with the criteria of reaction and the residual components were evaluated for bacterial contamination by Bac T/Alert system. RESULTS: Patients with leukemia or lymphoma transfused with random-donor PCs were evaluated the signs and symptoms of transfusion reaction occurred only in 12 (%0.4) cases. Automated cultivation found 3 positive blood cultures. Among these a male recipient was categorized as possible septic transfusion reaction and Citrobacterfreundii was isolated from blood sample. CONCLUSION: Appropriate clinical utilization of PCs transfusion, and ongoing vigilance to recognize, investigate, promptly treat, and report all suspicious transfusion reactions are necessary to manage the transfusion complication including transfusion-transmitted infections (TTI).
format Online
Article
Text
id pubmed-5831066
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Iranian Society of Pathology
record_format MEDLINE/PubMed
spelling pubmed-58310662018-03-07 Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases Razjou, Farhad Dabir Moghaddam, Abolfazl Karimi, Gharib Zadsar, Maryam Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Bacterial, contamination of blood components are a significant risk for transfusion reactions. Inherently, platelet concentrates (PCs) are vulnerable to bacterial contamination, due to the storage condition of processed PCs at room temperature, which provide very suitable conditions for the proliferation of microorganisms. The current study aimed at investigating the transfusion associated septic reaction rate in patients with hemato-oncological diseases in Imam Khomeini Hospital, Tehran, Iran, and identifying the contaminating bacteria. METHODS: A total of 3056 adult patients of the Cancer Center of Imam Khomeini Hospital in Tehran transfused with PCs were studied based on the clinical symptoms of septic transfusion reaction from June 1, 2010 to May 31, 2011. Patient presented with the criteria of reaction and the residual components were evaluated for bacterial contamination by Bac T/Alert system. RESULTS: Patients with leukemia or lymphoma transfused with random-donor PCs were evaluated the signs and symptoms of transfusion reaction occurred only in 12 (%0.4) cases. Automated cultivation found 3 positive blood cultures. Among these a male recipient was categorized as possible septic transfusion reaction and Citrobacterfreundii was isolated from blood sample. CONCLUSION: Appropriate clinical utilization of PCs transfusion, and ongoing vigilance to recognize, investigate, promptly treat, and report all suspicious transfusion reactions are necessary to manage the transfusion complication including transfusion-transmitted infections (TTI). Iranian Society of Pathology 2017 2017-04-01 /pmc/articles/PMC5831066/ /pubmed/29515632 Text en © 2017, IRANIAN JOURNAL OF PATHOLOGY. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Razjou, Farhad
Dabir Moghaddam, Abolfazl
Karimi, Gharib
Zadsar, Maryam
Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title_full Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title_fullStr Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title_full_unstemmed Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title_short Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
title_sort platelet septic transfusion reactions in patients with hemato-oncological diseases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831066/
https://www.ncbi.nlm.nih.gov/pubmed/29515632
work_keys_str_mv AT razjoufarhad plateletseptictransfusionreactionsinpatientswithhematooncologicaldiseases
AT dabirmoghaddamabolfazl plateletseptictransfusionreactionsinpatientswithhematooncologicaldiseases
AT karimigharib plateletseptictransfusionreactionsinpatientswithhematooncologicaldiseases
AT zadsarmaryam plateletseptictransfusionreactionsinpatientswithhematooncologicaldiseases